| Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis D Centonze, L Muzio, S Rossi, F Cavasinni, V De Chiara, A Bergami, ... Journal of Neuroscience 29 (11), 3442-3452, 2009 | 405 | 2009 |
| Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease C Liguori, A Romigi, M Nuccetelli, S Zannino, G Sancesario, A Martorana, ... JAMA neurology 71 (12), 1498-1505, 2014 | 292 | 2014 |
| Is dopamine involved in Alzheimer's disease? A Martorana, G Koch Frontiers in aging neuroscience 6, 252, 2014 | 291 | 2014 |
| Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease G Koch, S Bonnì, MC Pellicciari, EP Casula, M Mancini, R Esposito, ... Neuroimage 169, 302-311, 2018 | 290 | 2018 |
| Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? Z Esposito, L Belli, S Toniolo, G Sancesario, C Bianconi, A Martorana CNS neuroscience & therapeutics 19 (8), 549-555, 2013 | 240 | 2013 |
| Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? A Martorana, Z Esposito, G Koch CNS neuroscience & therapeutics 16 (4), 235-245, 2010 | 234 | 2010 |
| Impaired LTP-but not LTD-like cortical plasticity in Alzheimer's disease patients G Koch, F Di Lorenzo, S Bonnì, V Ponzo, C Caltagirone, A Martorana Journal of Alzheimer's Disease 31 (3), 593-599, 2012 | 157 | 2012 |
| Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients A Martorana, F Mori, Z Esposito, H Kusayanagi, F Monteleone, C Codeca, ... Neuropsychopharmacology 34 (10), 2323-2328, 2009 | 152 | 2009 |
| Dopaminergic modulation of cortical plasticity in Alzheimer’s disease patients G Koch, F Di Lorenzo, S Bonnì, V Giacobbe, M Bozzali, C Caltagirone, ... Neuropsychopharmacology 39 (11), 2654-2661, 2014 | 148 | 2014 |
| Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis S Rossi, R Furlan, V De Chiara, A Musella, TL Giudice, G Mataluni, ... Neurobiology of disease 36 (1), 51-59, 2009 | 145 | 2009 |
| Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats: An electron spectroscopy imaging and electron energy-loss spectroscopy study M Morello, A Canini, P Mattioli, RP Sorge, A Alimonti, B Bocca, G Forte, ... Neurotoxicology 29 (1), 60-72, 2008 | 128 | 2008 |
| Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's … C Liguori, M Nuccetelli, F Izzi, G Sancesario, A Romigi, A Martorana, ... Neurobiology of aging 40, 120-126, 2016 | 123 | 2016 |
| Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia A Benussi, F Di Lorenzo, V Dell'Era, M Cosseddu, A Alberici, ... Neurology 89 (7), 665-672, 2017 | 108 | 2017 |
| Lowered cAMP and cGMP signalling in the brain during levodopa‐induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms M Giorgi, V D’Angelo, Z Esposito, V Nuccetelli, R Sorge, A Martorana, ... European Journal of Neuroscience 28 (5), 941-950, 2008 | 108 | 2008 |
| Long‐term potentiation–like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset F Di Lorenzo, V Ponzo, S Bonnì, C Motta, PC Negrão Serra, M Bozzali, ... Annals of neurology 80 (2), 202-210, 2016 | 105 | 2016 |
| Differential post‐translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid A Biroccio, P Del Boccio, M Panella, S Bernardini, C Di Ilio, D Gambi, ... Proteomics 6 (7), 2305-2313, 2006 | 100 | 2006 |
| Immunolocalization of CB1 receptor in rat striatal neurons: A confocal microscopy study FR Fusco, A Martorana, C Giampa, Z De March, D Farini, V D'angelo, ... Synapse 53 (3), 159-167, 2004 | 100 | 2004 |
| Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients A Martorana, F Di Lorenzo, Z Esposito, TL Giudice, G Bernardi, ... Neuropharmacology 64, 108-113, 2013 | 91 | 2013 |
| Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial G Koch, EP Casula, S Bonnì, I Borghi, M Assogna, M Minei, MC Pellicciari, ... Brain 145 (11), 3776-3786, 2022 | 89 | 2022 |
| Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer’s disease C Motta, F Di Lorenzo, V Ponzo, MC Pellicciari, S Bonnì, S Picazio, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (12), 1237-1242, 2018 | 79 | 2018 |
